NCT05428501View on ClinicalTrials.gov

Awareness, Care & Treatment In Obesity Management - An Observation in Mainland China

CompletedOBSERVATIONAL

Enrollment

8,000

Participants

Timeline

Start Date

August 18, 2022

Primary Completion Date

November 30, 2022

Study Completion Date

November 30, 2022

Conditions

Obesity

Interventions

OTHER

no treatment given

People / Person Living with Obesity (PLwO) Health Care Professionals (HCPs)

Trial Locations (1)

Unknown

Novo Nordisk Investigational Site, Beijing

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY